Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2001 Apr;39(4):1647–1649. doi: 10.1128/JCM.39.4.1647-1649.2001

Evaluation of Candida ID, a New Chromogenic Medium for Fungal Isolation and Preliminary Identification of Some Yeast Species

H Fricker-Hidalgo 1,*, S Orenga 2, B Lebeau 1, H Pelloux 1, M P Brenier-Pinchart 1, P Ambroise-Thomas 1, R Grillot 1
PMCID: PMC87990  PMID: 11283107

Abstract

Candida ID, a new chromogenic medium, allows identification of Candida albicans (blue colonies) and preliminary identification into a group of four species (pink colonies). In comparison with Albicans ID2 and Sabouraud gentamicin chloramphenicol on 446 fungal strains, Candida ID allowed the isolation of more species than Albicans ID 2 (95.5% versus 91.2%).


Mycoses are a growing medical problem requiring prompt diagnosis with species identification and early adapted antifungal therapy (3, 7, 11, 14). The importance of identifying the pathogen quickly (20), as well as the difficulty in detecting mixed cultures in the same plate with the traditional Sabouraud glucose agar medium (2), has fostered the development of differential media for the identification of yeasts (1, 5, 6, 8, 12, 18, 19, 22). Candida ID (CAID) (bioMérieux, Marcy l'Etoile, France) is a recently commercialized, ready-to-use medium. CAID was developed to improve the isolation of yeasts, the identification of Candida albicans and C. dubliniensis, the detection of mixed cultures, and the preliminary identification of other species (C. tropicalis, C. guilliermondii, C. kefyr, and C. lusitaniae, which produce pink colonies). Further testing has to be performed to separate these four species. In our study, CAID was compared with Albicans ID2 (AID2) (bioMérieux) and Sabouraud gentamicin chloramphenicol agar (SGC) using 307 collection strains and 139 strains from 220 clinical samples.

A total of 307 fungal strains (247 yeasts and 60 filamentous fungi) from bioMérieux and Grenoble hospital collections were tested on the three media. The collection strains were subcultured on Sabouraud agar plates and incubated for 2 to 5 days at 35 or 27°C according to the species. For all isolates, a suspension of the organisms was made in physiological saline and seeded onto three plates (CAID, AID2, and SGC). The plates were incubated at 35°C except for Penicillium and Fusarium spp., which were incubated at 27°C. Equivalent amounts of each of the 220 clinical samples were directly applied to the three media and incubated at 35°C. The reading of the plates and interpretation of the results were carried out after 24, 48, and 72 h of incubation. The determination of the color, the number, and the diameter of the different colonies grown on CAID, AID2, and SGC was performed at each reading step. The colonies showing different morphologies on media inoculated with clinical samples were picked up and identified by conventional mycological methods (15): Bichrolatex albicans, Krusei color (Fumouze, Levallois-Perret, France) (13), ID32C (bioMérieux), and macroscopic and microscopic observations. The colony detections on CAID, AID2, and SGC were compared and analyzed in terms of sensitivity (number of true positives/number of true positives plus the number of false negatives) and specificity (number of true negatives/number of true negatives plus the number of false positives). The data were statistically analyzed by χ2 test. C. albicans identification on CAID and AID2 was analyzed in terms of sensitivity and specificity using the described conventional mycological methods as a reference.

CAID supported the growth of more strains (426 of 446, 95.5%) than AID2 (407 of 446, 91.2%) and as many as SGC (426 of 446, 95.5%) (Tables 1 and 2). The differences between CAID and AID2 were statistically significant (P < 0.025). Among the 220 clinical specimens, 103 gave positive cultures (43 stools, 14 tracheal fluids, 14 bronchoscopic aspirations, 30 sputum specimens, and 2 miscellaneous samples such as drain fluid) (Table 2). For the 31 polyfungal specimens, AID2 and CAID supported the growth of more fungus strains (62 of 67, 92.5%) than SGC (53 of 67, 79.1%), with statistically significant differences (P < 0.05). The sensitivities of CAID and AID2 for detection and differentiation of C. albicans were 97.6% (125 of 128) and 100% (128 of 128), respectively, and the specificities were 89.7 and 82.7%, respectively. The colonies of 17 among 36 isolates of C. tropicalis were blue on AID2 but not on CAID. CAID and AID2 did not enable differentiation between C. albicans and C. dubliniensis. On CAID, colonies of C. tropicalis (32 of 36), C. lusitaniae (10 of 10), C. guilliermondii (9 of 10), and C. kefyr (14 of 14) were pink after 72 h of incubation and needed complete identification. The time to detection of fungi growing on all three media (388 strains) were determined. After 24 h of incubation at 35°C, 90.7% (352 of 388) of the fungus strains were detected on SGC, 86.3% (335 of 388) were detected on AID2, and 89.7% (348 of 388) were detected on CAID. The average sizes of the colonies of collection strains after 24 h of incubation on SGC, AID2, and CAID were 0.63 ± 0.46, 0.86 ± 0.56, and 0.94 ± 0.55 mm, respectively. Bacteria were isolated from 23 of the 220 clinical samples (10.5%) on at least one of the three media. The numbers of bacterial strains isolated on SGC, AID2, and CAID were 14, 14, and 20, respectively.

TABLE 1.

Colonial coloration observed after 72 h of incubation on the three media. (SGC, AID2, and CAID) inoculated with 307 collection strains

Species No. of strains observed ona:
Any media SGC (white) AID2
CAID
White Blue White Blue Pink Other colors
Aspergillus flavus 5 5 5 5
Aspergillus fumigatus 9 9 9 9
Aspergillus nidulans 1 1 1 1
Aspergillus niger 5 5 5 5
Aspergillus terreus 3 3 3 3
Candida albicans 50 50 50 50
Candida colliculosa 4 4 1 2
Candida dubliniensis 10 10 10 10
Candida famata 5 5 2
Candida glabrata 10 10 10 10
Candida guilliermondii 10 10 10 1 9
Candida inconspicua 5 5 5 5
Candida intermedia 5 5 3 2 3
Candida kefyr 10 10 9 1 10
Candida krusei 10 10 10 10
Candida lipolytica 5 5 5 5
Candida lodderae 1 1 1 1
Candida lusitaniae 9 9 8 1 9
Candida norvegensis 5 5 3 2 3 1 1
Candida parapsilosis 10 10 10 10
Candida pelliculosa 5 5 5 2 3
Candida pulcherrima 5 5 5 5
Candida rugosa 5 5 3 2 4 1
Candida sake 1 1 1 1
Candida sphaerica 5 5 3 1 4
Candida tropicalis 29 29 14 15 1 27 1
Candida utillis 4 4 2 2 2
Candida zeylanoides 1 1
Cryptococcus albidus 4 4 2
Cryptococcus humicolus 4 4 3 4
Cryptococcus laurentii 3 3 1 1 1
Cryptococcus neoformans 10 10 8 1 3 6 1
Cryptococcus uniguttulatus 1 1
Fusarium sp. 2 2 2 2
Geotrichum candidum 5 5 5 5
Geotrichum capitatum 5 5 5 5
Penicillium sp. 4 4 4 4
Rhodotorula rubra 4 1 1 4
Saccharomyces cerevisiae 8 8 6 6
Scedosporium sp. 1 1 1 1
Trichosporum cutaneum 4 4 3 1 2
Trichosporon asahii 5 5 1 4 5
Trichosporon asahii/asteroides 4 4 1 3 1 3
Trichosporon inkin 5 5 1 4 5
Trichosporon mucoides 10 10 1 8 1 8 1
Zygosaccharomyces fermentati 1 1 1 1
a

Filamentous fungi, which initially appeared as white and moist colonies but then changed appearance depending on the species, are indicated by an asterisk. Total strains observed were as follows: any media, 307; SGC, 301; AID2, 274; CAID, 293. 

TABLE 2.

Colonial coloration observed after 72 h of incubation on the three media (SGC, AID2, and CAID) inoculated with 103 clinical samples

Species No. of fungal strains detected ona:
Any mediab SGC (white) AID2
CAID
White Blue White Blue Pink
Aspergillus fumigatus 11 6f 8f 10f
Candida albicans 78 76 78 1c 75
Candida glabrata 10 10 10 10
Candida kefyr 4 4 4 4
Candida krusei 7 7 6 7
Candida lusitaniae 1 1 1 1
Candida norvegensis 1 1
Candida parapsilosis 3 3 3 3
Candida tropicalis 7 5 5 2d 2e 5
Geotrichum candidum 7 6 7 6
Paecilomyces sp. 2 1f 1f
Saccharomyces cerevisiae 8 7 8 7
a

Total fungal strains detected: any media, 139; SGC, 125; AID2, 133; CAID, 133. 

b

Total number of fungal strains detected on at least one of the three media. 

c

The presence of bacteria has inhibited the coloration of yeast colonies. 

d

The colonies were blue with a white center. 

e

Case 1, the presence of bacteria has inhibited the coloration of yeast colonies, case 2, the colonies were pink after subculture. 

f

Filamentous fungi (initially appeared as white and moist colonies but then changed appearance depending on the species). 

CAID was developed to obtain better results than with AID2 (4, 9, 10, 17, 21). Our study showed that CAID allowed a better detection of different types of collection strains than AID2 (95.4 and 89.2%, respectively) and that the results from clinical samples were equivalent with CAID and AID2 (95.7%). The collection strains detected only on CAID belonged to species that were not isolated from the clinical samples in our study (C. colliculosa, C. famata, C. intermedia, C. sphaerica, C. utilis, C. zeylanoides, Cryptococcus humicolus, Cryptococcus laurentii, and Rhodotorula rubra). The other advantage of CAID related to the specificity of C. albicans identification. No C. tropicalis colonies were blue on CAID in contrast to what happens on AID2. C. lodderae and C. rugosa, which produce blue colonies on CAID, were rarely isolated from clinical specimens (16), blue Trichosporon colonies were easily differentiated from C. albicans by their macroscopic morphology, while C. dublinensis was not distinguished from C. albicans. Furthermore, when different yeast species were mixed in a single sample and plated out on CAID, the distinction between colony colors and forms was extremely easy to do. Discrimination of C. kefyr, C. lusitaniae, C. tropicalis, and C. guilliermondii from other yeasts by their pink colonies facilitates their definitive identification particularly for C. guilliermondii which has the same profile as C. famata on the ID32C strip. On CAID, the colonies of C. guilliermondii were pink while the colonies of C. famata were white; thus, no other complementary test (different from ID32C) was necessary.

In conclusion, our study shows that CAID is an effective, ready-to-use medium for the isolation of fungi and identification of C. albicans from samples in clinical laboratories.

Acknowledgments

We thank L. Barbaux, C. Cotte, A. Rongier, L. Coeur, C. Pinel, and A. De Bengy for their technical assistance and S. Bastin for rereading the manuscript.

REFERENCES

  • 1.Ainscough S, Kibbler C C. An evaluation of the cost-effectiveness of using Chromagar for yeast identification in a routine microbiology laboratory. J Med Microbiol. 1998;47:623–628. doi: 10.1099/00222615-47-7-623. [DOI] [PubMed] [Google Scholar]
  • 2.Al Hedaithy S S A, Fotedar R. Recovery of multiple species of yeasts from single clinical specimen culture. J Mycol Med. 1998;8:153–155. [Google Scholar]
  • 3.Anaissie E J. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis. 1992;14(Suppl. 1):S43–S51. doi: 10.1093/clinids/14.supplement_1.s43. [DOI] [PubMed] [Google Scholar]
  • 4.Baumgartner C, Freydière A M, Gille Y. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J Clin Microbiol. 1996;34:454–456. doi: 10.1128/jcm.34.2.454-456.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Beighton D, Ludford R, Clark D T, Brailsford S R, Pankhurst C L, Tinsley G F, Fiske J, Lewis D, Daly B, Khalifa N, Marren V, Lynch E. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol. 1995;33:3025–3027. doi: 10.1128/jcm.33.11.3025-3027.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bouchara J P, Declerck P, Cimon B, Planchenault C, de Gentile L, Chabasse D. Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations. Clin Microbiol Infect. 1996;2:202–208. doi: 10.1016/s1198-743x(14)65143-0. [DOI] [PubMed] [Google Scholar]
  • 7.Buchaille L, Freydière A M, Guinet R, Gille Y. Evaluation of six commercial systems for identification of medically important yeasts. Eur J Clin Microbiol Infect Dis. 1998;17:479–488. doi: 10.1007/BF01691130. [DOI] [PubMed] [Google Scholar]
  • 8.Campbell C K, Holmes A D, Davey K G, Szekely A, Warnock D W. Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans. Eur J Clin Microbiol Infect Dis. 1998;17:367–368. doi: 10.1007/BF01709466. [DOI] [PubMed] [Google Scholar]
  • 9.Contreras I, San-Millan R, Agustin-Barrasa A, Ponton J, Quindos G. Utility of Albicans ID plate for rapid identification of Candida albicans in clinical samples. Mycopathologia. 1996;136:17–20. doi: 10.1007/BF00436655. [DOI] [PubMed] [Google Scholar]
  • 10.De Champs C, Lebeau B, Ambroise-Thomas P, Grillot R. Evaluation of Albicans ID plates. J Clin Microbiol. 1995;33:2227–2228. doi: 10.1128/jcm.33.8.2227-2228.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Edwards J E, et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. 1997. Clin Infect Dis. 1997;25:43–59. doi: 10.1086/514504. [DOI] [PubMed] [Google Scholar]
  • 12.Freydière A M, Buchaille L, Gille Y. Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens. Eur J Clin Microbiol Infect Dis. 1997;16:464–467. doi: 10.1007/BF02471913. [DOI] [PubMed] [Google Scholar]
  • 13.Freydière A M, Buchaille L, Guinet R, Gille Y. Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies. J Clin Microbiol. 1997;35:877–880. doi: 10.1128/jcm.35.4.877-880.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Freydière A M, Guinet R. Rapid methods for identification of the most frequent clinical yeasts. Rev Iberoam Micol. 1997;14:82–87. [PubMed] [Google Scholar]
  • 15.Grillot R. Les mycoses humaines: démarche diagnostique. Paris, France: Elsevier; 1996. [Google Scholar]
  • 16.Hazen K C. New and emerging yeast pathogens. Clin Microbiol Rev. 1995;8:462–478. doi: 10.1128/cmr.8.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lipperheide V, Andraka L, Ponton J, Quindos G. Evaluation of the Albicans ID® plate method for the rapid identification of Candida albicans. Mycoses. 1993;36:417–420. doi: 10.1111/j.1439-0507.1993.tb00731.x. [DOI] [PubMed] [Google Scholar]
  • 18.Odds F C, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;32:1923–1929. doi: 10.1128/jcm.32.8.1923-1929.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Pfaller M A, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei and Candida (Torulopsis) glabrata. 1996. J Clin Microbiol. 1996;34:58–61. doi: 10.1128/jcm.34.1.58-61.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Rex J H, Rinaldi M G, Pfaller M A. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother. 1995;39:1–8. doi: 10.1128/aac.39.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rousselle P, Freydière A M, Couillerot P J, de Montclos H, Gille Y. Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates. J Clin Microbiol. 1994;32:3034–3036. doi: 10.1128/jcm.32.12.3034-3036.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.San-Millan R, Ribacoba L, Ponton J, Quindos G. Evaluation of a commercial medium for identification of Candida species. Eur J Clin Microbiol Infect Dis. 1996;15:153–158. doi: 10.1007/BF01591489. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES